​
ログむン

BALUT TUWING GABI 🐣

BALUT TUWING GABI 🐣
63問 • 1幎前
  • Yves Laure Pimentel
  • 通報

    問題䞀芧

  • 1

    : Single-cell prokaryotic microorganisms

    BACTERIA

  • 2

    : Single-cell or multicellular eukaryotic organisms

    FUNGI, PARASITES

  • 3

    : Unicellular eukaryotic organisms

    YEASTS

  • 4

    : Dependent on host cells for survival and therefore are not considered cellular organisms but rather INFECTIOUS AGENTS

    VIRUSES

  • 5

    VIRUSES: Dependent on host cells for survival and therefore are not considered cellular organisms but rather

    INFECTIOUS AGENTS

  • 6

    : Most common method of treating infectious waste; SAFEST METHOD to ensure that no infective materials remain in samples or containers when disposed

    INCINERATION

  • 7

    INCINERATION: Most common method of treating infectious waste; ____ to ensure that no infective materials remain in samples or containers when disposed

    SAFEST METHOD

  • 8

    MOST IMPORTANT PART OF HAND WASHING: Mechanical action of ? and soaping under the fingernails

    rubbing the hands together

  • 9

    : Sensitive to temperature changes

    N. meningitidis

  • 10

    .: Sensitive to changes in pH

    Shigella spp

  • 11

    : Determination of inducible-clindamycin resistance in staphylococci and streptococci

    D-ZONE TEST

  • 12

    : Gray, translucent, smooth, glistening; may have dry, CLAYLIKE CONSISTENCY

    Neisseria elongata

  • 13

    : Friable “hockey puck” consistency

    Moraxella catarrhalis

  • 14

    : NORMAL FLORA of the human conjunctiva, skin and nasopharynx

    Corynebacterium amycolatum

  • 15

    : 0.5% sodium deoxycholate lyses Vibrio cells; used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    STRING TEST

  • 16

    STRING TEST: ? lyses Vibrio cells; used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    0.5% sodium deoxycholate

  • 17

    used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    STRING TEST

  • 18

    : Chancroid, soft chancre, School of fish arrangement, railroad track appearance

    Haemophilus ducreyi

  • 19

    : Large; boxcar shape

    C. perfringens

  • 20

    TRUE GERM TUBE:

    C. albicans, C. dubliniensis

  • 21

    : C. albicans, C. dubliniensis

    TRUE GERM TUBE

  • 22

    : Subacute sclerosing panencephalitis (SSPE)

    MEASLES VIRUS

  • 23

    MEASLES VIRUS:

    Subacute sclerosing panencephalitis (SSPE)

  • 24

    : LOEFFLER’S SYNDROME (transient pulmonary infiltration; day-to-day clearing in 3 to 14 days; associated with marked peripheral eosinophilia)

    Ascaris lumbricoides

  • 25

    Ascaris lumbricoides: ? (transient pulmonary infiltration; day-to-day clearing in 3 to 14 days; associated with marked peripheral eosinophilia)

    LOEFFLER’S SYNDROME

  • 26

    : Swollen belly syndrome

    Strongyloides fuelleborni

  • 27

    (abdominal angiostrongyliasis): Patient may experience lower right quadrant; ABDOMINAL PAIN SIMILAR TO THAT MANIFESTED IN APPENDICITIS

    Parastrongylus costaricensis

  • 28

    is an INTEGRAL PART of the transmission of nerve impulses.

    Potassium

  • 29

    Potassium is an ? of the transmission of nerve impulses.

    INTEGRAL PART

  • 30

    is the major intracellular cation in the body.

    POTASSIUM (K+)

  • 31

    Functions in the body include regulation of neuromuscular excitability, contraction of the heart, ICF volume, and H+ concentration.

    K+

  • 32

    is the most abundant cation in the ECF, representing 90% of all extracellular cations, and largely determines the osmolality of the plasma.

    SODIUM (Na+)

  • 33

    is the major extracellular anion. It is involved in maintaining osmolality, blood volume, and electric neutrality. In most processes,

    CHLORIDE (Cl-)

  • 34

    shifts secondarily to a movement of Na+ or HCO3−.

    Cl−

  • 35

    is involved in blood coagulation, enzyme activity, excitability of skeletal and cardiac muscle and maintenance of blood pressure. It is essential for myocardial contraction.

    CALCIUM (Ca2+)

  • 36

    Three hormones: - regulate serum CALCIUM.

    PARATHYROID HORMONE, VITAMIN D, AND CALCITONIN

  • 37

    in inversely related to calcium. Phosphate is essential for the insulin mediated entry of glucose into cells by a process involving phosphorylation and co-entry of potassium.

    PHOSPHORUS

  • 38

    is essential for the insulin mediated entry of glucose into cells by a process involving phosphorylation and co-entry of potassium.

    Phosphate

  • 39

    is the fourth most abundant cation in the body and second most abundant intracellular ion. It is an essential cofactor of more than 300 enzymes, including those important in glycolysis; transcellular ion transport; neuromuscular transmission; synthesis of carbohydrates, proteins, lipids, and nucleic acids; and the release of and response to certain hormones.

    MAGNESIUM (Mg2+)

  • 40

    Fever will decrease

    pO2 by 7 %

  • 41

    Fever will increase

    pCO2 by 3 %

  • 42

    Forward reaction for CK (creatine to creatine phosphate):

    Tanzer-Gilvarg

  • 43

    Forward reaction for CK (?): Tanzer-Gilvarg

    creatine to creatine phosphate

  • 44

    reaction for CK (creatine to creatine phosphate): Tanzer-Gilvarg

    Forward

  • 45

    Reverse reaction for CK (creatine phosphate to creatine):

    Oliver-Rosalki

  • 46

    Reverse reaction for CK (?): Oliver-Rosalki

    creatine phosphate to creatine

  • 47

    reaction for CK (creatine phosphate to creatine): Oliver-Rosalki

    Reverse

  • 48

    Forward reaction for LD (lactate to pyruvate):

    Wacker

  • 49

    Forward reaction for LD (?): Wacker

    lactate to pyruvate

  • 50

    reaction for LD (lactate to pyruvate): Wacker

    Forward

  • 51

    Reverse reaction for LD (pyruvate to lactate):

    Wroblewski LaDue

  • 52

    reaction for LD (pyruvate to lactate): Wroblewski LaDue

    Reverse

  • 53

    Reverse reaction for LD (?): Wroblewski LaDue

    pyruvate to lactate

  • 54

    Most potent of the estrogens:

    Estradiol (E2)

  • 55

    Confirmatory test for acromegaly:

    Glucose suppression test - OGTT

  • 56

    Cholesterol and triglycerides in hypothyroidism:

    Increased

  • 57

    Cholesterol and triglycerides in ?: Increased

    hypothyroidism

  • 58

    Cholesterol and triglycerides in hyperthyroidism:

    Decreased

  • 59

    Cholesterol and triglycerides in ?: Decreased

    hyperthyroidism

  • 60

    Metabolite of cocaine:

    Benzoylecgonine

  • 61

    Metabolite of ?: Benzoylecgonine

    cocaine

  • 62

    BMI of obese:

    ≥ 30 kg/m2

  • 63

    BMI of ?: ≥ 30 kg/m2

    obese

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2幎前

    other names parasitology

    other names parasitology

    70問 • 2幎前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2幎前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2幎前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2幎前

    HTMLBE

    HTMLBE

    64問 • 2幎前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2幎前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2幎前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2幎前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2幎前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2幎前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2幎前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2幎前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2幎前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2幎前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2幎前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2幎前

    CSF 1

    CSF 1

    100問 • 2幎前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2幎前

    CSF 2

    CSF 2

    82問 • 2幎前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2幎前

    SEMEN 1

    SEMEN 1

    100問 • 2幎前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2幎前

    SEMEN 2

    SEMEN 2

    7問 • 2幎前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2幎前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2幎前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2幎前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2幎前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2幎前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2幎前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2幎前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2幎前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2幎前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2幎前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2幎前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2幎前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2幎前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2幎前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2幎前

    FECALYSIS

    FECALYSIS

    80問 • 2幎前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2幎前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2幎前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2幎前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2幎前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2幎前

    MTLBE..

    MTLBE..

    35問 • 2幎前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1幎前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1幎前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1幎前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1幎前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1幎前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1幎前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2幎前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2幎前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2幎前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2幎前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2幎前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2幎前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2幎前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2幎前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2幎前

    PROTEINS

    PROTEINS

    37問 • 2幎前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2幎前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2幎前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2幎前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2幎前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2幎前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2幎前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2幎前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2幎前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2幎前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2幎前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2幎前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2幎前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2幎前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2幎前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2幎前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2幎前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2幎前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2幎前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2幎前

    PROTEINS

    PROTEINS

    71問 • 2幎前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2幎前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2幎前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2幎前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2幎前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2幎前

    DRUGS

    DRUGS

    27問 • 2幎前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2幎前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2幎前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2幎前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2幎前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2幎前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2幎前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2幎前

    hema diseases

    hema diseases

    25問 • 2幎前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2幎前

    AML

    AML

    43問 • 2幎前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2幎前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2幎前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2幎前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2幎前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2幎前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2幎前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2幎前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2幎前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2幎前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2幎前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2幎前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2幎前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2幎前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2幎前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2幎前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2幎前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2幎前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2幎前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2幎前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2幎前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2幎前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2幎前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2幎前

    1. HISTORY

    1. HISTORY

    69問 • 2幎前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2幎前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2幎前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2幎前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2幎前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2幎前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2幎前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2幎前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2幎前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2幎前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2幎前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2幎前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2幎前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2幎前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2幎前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2幎前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2幎前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2幎前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2幎前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2幎前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2幎前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2幎前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2幎前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2幎前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2幎前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2幎前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2幎前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2幎前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2幎前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2幎前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2幎前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2幎前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2幎前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2幎前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2幎前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2幎前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2幎前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2幎前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2幎前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2幎前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2幎前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2幎前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2幎前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2幎前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2幎前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2幎前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2幎前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2幎前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2幎前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2幎前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2幎前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2幎前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2幎前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2幎前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2幎前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2幎前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2幎前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2幎前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2幎前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2幎前

    1. SERO

    1. SERO

    54問 • 2幎前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2幎前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2幎前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2幎前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2幎前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2幎前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2幎前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2幎前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2幎前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2幎前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2幎前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2幎前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2幎前
    Yves Laure Pimentel

    問題䞀芧

  • 1

    : Single-cell prokaryotic microorganisms

    BACTERIA

  • 2

    : Single-cell or multicellular eukaryotic organisms

    FUNGI, PARASITES

  • 3

    : Unicellular eukaryotic organisms

    YEASTS

  • 4

    : Dependent on host cells for survival and therefore are not considered cellular organisms but rather INFECTIOUS AGENTS

    VIRUSES

  • 5

    VIRUSES: Dependent on host cells for survival and therefore are not considered cellular organisms but rather

    INFECTIOUS AGENTS

  • 6

    : Most common method of treating infectious waste; SAFEST METHOD to ensure that no infective materials remain in samples or containers when disposed

    INCINERATION

  • 7

    INCINERATION: Most common method of treating infectious waste; ____ to ensure that no infective materials remain in samples or containers when disposed

    SAFEST METHOD

  • 8

    MOST IMPORTANT PART OF HAND WASHING: Mechanical action of ? and soaping under the fingernails

    rubbing the hands together

  • 9

    : Sensitive to temperature changes

    N. meningitidis

  • 10

    .: Sensitive to changes in pH

    Shigella spp

  • 11

    : Determination of inducible-clindamycin resistance in staphylococci and streptococci

    D-ZONE TEST

  • 12

    : Gray, translucent, smooth, glistening; may have dry, CLAYLIKE CONSISTENCY

    Neisseria elongata

  • 13

    : Friable “hockey puck” consistency

    Moraxella catarrhalis

  • 14

    : NORMAL FLORA of the human conjunctiva, skin and nasopharynx

    Corynebacterium amycolatum

  • 15

    : 0.5% sodium deoxycholate lyses Vibrio cells; used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    STRING TEST

  • 16

    STRING TEST: ? lyses Vibrio cells; used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    0.5% sodium deoxycholate

  • 17

    used to differentiate Vibrio spp. (positive) from Aeromonas spp. and P. shigelloides (negative)

    STRING TEST

  • 18

    : Chancroid, soft chancre, School of fish arrangement, railroad track appearance

    Haemophilus ducreyi

  • 19

    : Large; boxcar shape

    C. perfringens

  • 20

    TRUE GERM TUBE:

    C. albicans, C. dubliniensis

  • 21

    : C. albicans, C. dubliniensis

    TRUE GERM TUBE

  • 22

    : Subacute sclerosing panencephalitis (SSPE)

    MEASLES VIRUS

  • 23

    MEASLES VIRUS:

    Subacute sclerosing panencephalitis (SSPE)

  • 24

    : LOEFFLER’S SYNDROME (transient pulmonary infiltration; day-to-day clearing in 3 to 14 days; associated with marked peripheral eosinophilia)

    Ascaris lumbricoides

  • 25

    Ascaris lumbricoides: ? (transient pulmonary infiltration; day-to-day clearing in 3 to 14 days; associated with marked peripheral eosinophilia)

    LOEFFLER’S SYNDROME

  • 26

    : Swollen belly syndrome

    Strongyloides fuelleborni

  • 27

    (abdominal angiostrongyliasis): Patient may experience lower right quadrant; ABDOMINAL PAIN SIMILAR TO THAT MANIFESTED IN APPENDICITIS

    Parastrongylus costaricensis

  • 28

    is an INTEGRAL PART of the transmission of nerve impulses.

    Potassium

  • 29

    Potassium is an ? of the transmission of nerve impulses.

    INTEGRAL PART

  • 30

    is the major intracellular cation in the body.

    POTASSIUM (K+)

  • 31

    Functions in the body include regulation of neuromuscular excitability, contraction of the heart, ICF volume, and H+ concentration.

    K+

  • 32

    is the most abundant cation in the ECF, representing 90% of all extracellular cations, and largely determines the osmolality of the plasma.

    SODIUM (Na+)

  • 33

    is the major extracellular anion. It is involved in maintaining osmolality, blood volume, and electric neutrality. In most processes,

    CHLORIDE (Cl-)

  • 34

    shifts secondarily to a movement of Na+ or HCO3−.

    Cl−

  • 35

    is involved in blood coagulation, enzyme activity, excitability of skeletal and cardiac muscle and maintenance of blood pressure. It is essential for myocardial contraction.

    CALCIUM (Ca2+)

  • 36

    Three hormones: - regulate serum CALCIUM.

    PARATHYROID HORMONE, VITAMIN D, AND CALCITONIN

  • 37

    in inversely related to calcium. Phosphate is essential for the insulin mediated entry of glucose into cells by a process involving phosphorylation and co-entry of potassium.

    PHOSPHORUS

  • 38

    is essential for the insulin mediated entry of glucose into cells by a process involving phosphorylation and co-entry of potassium.

    Phosphate

  • 39

    is the fourth most abundant cation in the body and second most abundant intracellular ion. It is an essential cofactor of more than 300 enzymes, including those important in glycolysis; transcellular ion transport; neuromuscular transmission; synthesis of carbohydrates, proteins, lipids, and nucleic acids; and the release of and response to certain hormones.

    MAGNESIUM (Mg2+)

  • 40

    Fever will decrease

    pO2 by 7 %

  • 41

    Fever will increase

    pCO2 by 3 %

  • 42

    Forward reaction for CK (creatine to creatine phosphate):

    Tanzer-Gilvarg

  • 43

    Forward reaction for CK (?): Tanzer-Gilvarg

    creatine to creatine phosphate

  • 44

    reaction for CK (creatine to creatine phosphate): Tanzer-Gilvarg

    Forward

  • 45

    Reverse reaction for CK (creatine phosphate to creatine):

    Oliver-Rosalki

  • 46

    Reverse reaction for CK (?): Oliver-Rosalki

    creatine phosphate to creatine

  • 47

    reaction for CK (creatine phosphate to creatine): Oliver-Rosalki

    Reverse

  • 48

    Forward reaction for LD (lactate to pyruvate):

    Wacker

  • 49

    Forward reaction for LD (?): Wacker

    lactate to pyruvate

  • 50

    reaction for LD (lactate to pyruvate): Wacker

    Forward

  • 51

    Reverse reaction for LD (pyruvate to lactate):

    Wroblewski LaDue

  • 52

    reaction for LD (pyruvate to lactate): Wroblewski LaDue

    Reverse

  • 53

    Reverse reaction for LD (?): Wroblewski LaDue

    pyruvate to lactate

  • 54

    Most potent of the estrogens:

    Estradiol (E2)

  • 55

    Confirmatory test for acromegaly:

    Glucose suppression test - OGTT

  • 56

    Cholesterol and triglycerides in hypothyroidism:

    Increased

  • 57

    Cholesterol and triglycerides in ?: Increased

    hypothyroidism

  • 58

    Cholesterol and triglycerides in hyperthyroidism:

    Decreased

  • 59

    Cholesterol and triglycerides in ?: Decreased

    hyperthyroidism

  • 60

    Metabolite of cocaine:

    Benzoylecgonine

  • 61

    Metabolite of ?: Benzoylecgonine

    cocaine

  • 62

    BMI of obese:

    ≥ 30 kg/m2

  • 63

    BMI of ?: ≥ 30 kg/m2

    obese